KOREAN ENGLISH CONTACT US SITEMAP
logo
  • Company
    • Company Introduction
    • CEO Greeting
    • Organization Map
    • Management Philosophy
    • Certifications and Patents
    • Directions
  • Products
    • Diagnostic Kits
    • Antiviral agent (VSF)
    • Products under development
  • R & D
    • Antiviral agent
    • Infectious Diseases
    • Research Projects
  • Company News
    • Notice
    • Press Release
    • Exhibition
  • Investment Information
    • Notice
    • Financial Information
    • Investment Inquiry

CEO Greeting

Home CEO Greeting

“Contribution to the healthy life of mankind liberated from infectious diseases”

Dr. Yoon-won Kim
CEO, ImmuneMed Inc.

Human beings have been suffering from the various infectious diseases since the history of evolution of mankind. By virtue of the development of the modern medicines, many diseases have been possible to overcome and cured.
Nevertheless, lots of more unpredictable and untreatable diseases still exist. Even though human beings, the superior form of all creations, are still suffering from the lower microorganisms such as viruses, not enough solutions are provided from the current modern medicines regretfully. As a scientist, I have put all my research efforts into discovering the new potent antiviral therapeutics to overcome the limitations of the conventional antiviral drugs. As a result of strenuous more than 25 years research, I have miraculously discovered several antiviral substances. One of them is named as VSF (Virus Suppressing Factor) which shows superior antiviral activities exceeding those of previously known antiviral substances such as interferon. VSF is expected to show an unprecedented and potent broad spectrum of antiviral activity.

I think that the development of VSF as a therapeutic drug could be an unparalleled breakthrough in the treatment of incurable viral diseases of modern times.

Being free from infectious diseases has been ImmuneMed’s core objective. We believe that VSF will be a breakthrough in the near future to improve human health. I am proud to announce that our dedicated team of researchers is working strenuously in order to open a new breakthrough era of antiviral therapy for the betterment of healthier human life.

Dr. Yoon-won Kim CEO, ImmuneMed Inc.

Headquarters

  • Room #2-2, Building #3, Chuncheon Bio Town, 32, Soyanggang-ro, Chuncheon-si, Gangwon-do, 24232, Republic of Korea
  • Tel : +82-33-258-6554
  • Fax : +82-33-258-6553

Seoul office

  • Room #1418, Building #C, (SK V1 GL Metrocity) 128, Beobwon-ro, Songpa-gu, Seoul, 05854, Republic of Korea
  • Tel : +82-2-527-8390
  • Fax : +82-2-527-8392

New Drug Development Center

  • 5th and 6th Floors, School of Medicine, Hallym University, 1, Hallymdaehak-gil, Chuncheon-si, Gangwon-do, 24252, Republic of Korea
  • Tel : +82-33-253-1669
  • Fax : +82-33-258-6553

Diagnostic Development Laboratory and Production Plant

  • Rooms #209 and #210, Building #1 & Room #2-3, Building #3, Chuncheon Bio Town, 32, Soyanggang-ro, Chuncheon-si, Gangwon-do, 24232, Republic of Korea
  • Tel : +82-33-258-6550
  • Fax : +82-33-258-6553
COPYRIGHT ⓒ 2018 immunemed.Inc., ALL RIGHTS RESERVED.